Welcome to our dedicated page for First Choice Hea news (Ticker: FCHS), a resource for investors and traders seeking the latest updates and insights on First Choice Hea stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect First Choice Hea's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of First Choice Hea's position in the market.
First Choice Healthcare Solutions (OTC:FCHS) announced that its Board-approved 1-for-2,000 reverse stock split will consolidate the 32,958,288 common shares outstanding as of June 30, 2026 into approximately 16,429 common shares. Each 2,000 issued and outstanding common shares will automatically convert into roughly one share.
According to First Choice Healthcare Solutions, the reverse split will occur immediately after the planned Form 15 filing or after the effectiveness of the Form F 4 registration statement with the SEC, but before the company’s planned Nasdaq listing tied to its proposed business combination announced on July 22, 2026. The reverse split will not apply to nonpublic investment instruments that were consolidated into Series C Preferred securities and Bridge debtholders with conversion rights and commitment shares as of May 7, 2026.